Targeting CXCR1 and CXCR2 to overcome radiotherapy resistance in PTEN-deficient prostate carcinoma (2020)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2020.03.16.993394

Publication URI: http://dx.doi.org/10.1101/2020.03.16.993394

Type: Preprint